ZNTL (Zentalis Pharmaceuticals) FCF Margin %: 0.00% (As of Mar. 2026)


ZNTL Zentalis Pharmaceuticals Inc ZNTL
30 GF Score
Price $4.72
! 3 Warning Signs
View Full Analysis

What is Zentalis Pharmaceuticals FCF Margin %?

Zentalis Pharmaceuticals ZNTL -1.26% 30 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates ZNTL with a GF Score™ of 30/100. The stock has 3 warning signs investors should review. Among 947 Biotechnology companies, Zentalis Pharmaceuticals ranks worse than 105596.52% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Zentalis Pharmaceuticals's Free Cash Flow for the three months ended in Mar. 2026 was $-32.99 Mil. Zentalis Pharmaceuticals's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Zentalis Pharmaceuticals's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Zentalis Pharmaceuticals's current FCF Yield % is -37.38%.

The historical rank and industry rank for Zentalis Pharmaceuticals's FCF Margin % or its related term are showing as below:


During the past 8 years, the highest FCF Margin % of Zentalis Pharmaceuticals was -253.74%. The lowest was -174842.86%. And the median was -87548.30%.

ZNTL's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -82.65
* Ranked among companies with meaningful FCF Margin % only.

Zentalis Pharmaceuticals FCF Margin % Related Terms

Zentalis Pharmaceuticals FCF Margin % Historical Data

* Premium members only.

The historical data trend for Zentalis Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zentalis Pharmaceuticals FCF Margin % Chart

Zentalis Pharmaceuticals Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 -253.74 0.00

Zentalis Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ZNTL vs ELDN, GLSI, SABS: FCF Margin % Comparison

For the Biotechnology subindustry, Zentalis Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zentalis Pharmaceuticals FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zentalis Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Zentalis Pharmaceuticals's FCF Margin % falls into.


ZNTL
30GF Score
Zentalis Pharmaceuticals Inc ZNTL
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zentalis Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Zentalis Pharmaceuticals's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-125.247/0
= %

Zentalis Pharmaceuticals's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-32.99/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Zentalis Pharmaceuticals (ZNTL) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Zentalis Pharmaceuticals and its competitors. According to the industry distribution chart, Zentalis Pharmaceuticals ranks #999999 out of 947 companies in the Biotechnology industry.
Is Zentalis Pharmaceuticals' FCF Margin % too high?
Zentalis Pharmaceuticals' current FCF Margin % is 0.00%. Based on the distribution chart, Zentalis Pharmaceuticals ranks #999999 out of 947 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Zentalis Pharmaceuticals has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Zentalis Pharmaceuticals' FCF Margin % compare to ELDN and GLSI?
According to the Biotechnology industry distribution chart, Zentalis Pharmaceuticals ranks #999999 out of 947 companies for FCF Margin %. This places Zentalis Pharmaceuticals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Zentalis Pharmaceuticals and its competitors. Zentalis Pharmaceuticals's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zentalis Pharmaceuticals stock overvalued right now?
Zentalis Pharmaceuticals (ZNTL) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Zentalis Pharmaceuticals' overall GF Score™ is 30/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Zentalis Pharmaceuticals (ZNTL), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zentalis Pharmaceuticals Business Description

Address 10275 Science Center Drive, Suite 200, San Diego, CA, USA, 92121
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
30GF Score

Get the complete analysis for ZNTL

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.72
Price